Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Southern Africa has been experiencing some interesting trends and developments in recent years.
Customer preferences: Customers in Southern Africa have shown a growing interest in preventative healthcare, including vaccination against diseases. This trend has been driven by increasing awareness of the benefits of vaccination, as well as the growing availability of vaccines in the region.
Trends in the market: One major trend in the Other Vaccines market in Southern Africa is the increasing demand for vaccines against infectious diseases such as meningitis, yellow fever, and hepatitis. This trend is driven by a combination of factors, including rising public awareness of the risks associated with these diseases, increasing travel within the region, and the growing availability of vaccines.Another trend in the market is the growing use of combination vaccines, which offer protection against multiple diseases in a single shot. This trend is driven by the convenience and cost-effectiveness of combination vaccines, as well as the growing availability of these products in the region.
Local special circumstances: Southern Africa is home to a number of unique health challenges, including a high incidence of infectious diseases such as malaria, tuberculosis, and HIV/AIDS. These challenges have helped to drive demand for vaccines in the region, as customers seek to protect themselves against these and other diseases.
Underlying macroeconomic factors: The Other Vaccines market in Southern Africa is influenced by a range of macroeconomic factors, including government policy, healthcare infrastructure, and economic growth. In recent years, governments in the region have increased their focus on healthcare, investing in new facilities and programs to improve access to healthcare services. At the same time, economic growth in the region has helped to drive demand for healthcare products and services, including vaccines.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
